Skip to main content
. 2022 Nov 8;23(22):13722. doi: 10.3390/ijms232213722

Table 4.

Summary of the effects of constant light (LL) on the immune parameters under steady state and challenged conditions in rodents.

Species LL Intensity
and Duration
Immune Challenge Effects Ref.
Sprague-Dawley rats 300 lx for 17 weeks
and 16 weeks of re-synchronization
Lost 24 h rhythm in blood leukocytes after 11/16 weeks in LL, (the rhythm was not restored after 16 weeks of re-synchronization in LD regime)
↓ NK cell counts in the blood
[158]
Wistar rats 150 lx for 4 weeks Activated pro-inflammatory state (↑ expression of Stat3, Il-1α and Il-17ra) in the colonic mucosa [151]
Wistar rats 200–250 lx for 5 weeks LPS 2 µg/kg (i.v.) ↑ plasma TNFα response and sickness symptoms upon LPS [152]
Wistar rats 200–250 lx for 5 weeks C6 tumor cells (s.c.) ↑ tumor growth
↑ tumor infiltration of monocytes/macrophages
[152]
Sprague-Dawley rats 200 lx for 7 days Endotoxemia model
(daily i.p. LPS injection for 7 days)
↑ hypothalamic expression of Il-1β and Tnfα [159]
C56BL/6J mice 105 lx for 24 weeks LPS 50 µg/kg (i.v.) Transient ↑ of neutrophil and ↓ of lymphocyte numbers in the blood was associated with enhanced inflammatory response to LPS (↑ IL-1β, TNFα, IL-6, and ↓ IL-10 plasma levels) after 8 weeks of LL
No immune changes after 24 weeks of LL
[154]
CD-1 mice 750 lx for 4 weeks Complete Freund’s adjuvant (100 µL) ↑ proportion of myeloid-derived suppressor cells in the spleen under LL was potentiated by chronic inflammation
↑ plasma TGF-β1 levels and ↑ chronic inflammation induced elevation of IL-6 levels
[160]

IL—interleukin; LD—light/dark; LPS—lipopolysaccharide; STAT3—signal transducer and activator of transcription 3; TGF-β1—transforming growth factor beta 1; TNFα—tumor necrosis factor-alpha.